Cargando…
Systematic review of diffuse hemispheric glioma, H3 G34-mutant: Outcomes and associated clinical factors
BACKGROUND: A comprehensive review and description of the clinical features that impact prognosis for patients with diffuse hemispheric glioma, H3 G34-mutant (G34-DHG) is needed. Understanding survival and prognostic features is paramount for clinical advancements and patient care. METHODS: PubMed,...
Autores principales: | Crowell, Cameron, Mata-Mbemba, Daddy, Bennett, Julie, Matheson, Kara, Mackley, Michael, Perreault, Sébastien, Erker, Craig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9466272/ https://www.ncbi.nlm.nih.gov/pubmed/36105387 http://dx.doi.org/10.1093/noajnl/vdac133 |
Ejemplares similares
-
HGG-05. Systematic review of diffuse hemispheric glioma, H3 G34-mutant and clinical factors influencing outcomes
por: Crowell, Cameron, et al.
Publicado: (2022) -
Upfront BRAF/MEK inhibitors for treatment of high-grade glioma: A case report and review of the literature
por: Arbour, Gabrielle, et al.
Publicado: (2022) -
LGG-08. MR Imaging of pediatric low-grade gliomas: Pretherapeutic differentiation ofBRAF V600E mutation,BRAF-Fused and Wild-Type tumors in patients without Neurofibromatosis-1
por: Trasolini, Andrew, et al.
Publicado: (2022) -
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults
por: Picart, Thiébaud, et al.
Publicado: (2021) -
SDPS-08 OSSEOUS METASTASES IN H3G34-MUTANT DIFFUSE HEMISPHERIC GLIOMAS
por: Yu, Nina, et al.
Publicado: (2023)